Anticancer composition

Abstract

An anticancer composition containing a flowery portion of elm tree or its extract and a leaf portion of varnish tree or its extract is safe and shows high activity.

1 . A pharmaceutical composition for treating a cancer, comprising a flowery portion of elm tree or its extract and a leaf portion of varnish tree or its extract, wherein the cancer is at least one selected from the group consisting of malignant sarcoma, malignant adenoma, hemangiosarcoma, non-Hodgkin lymphoma, mesenchymal tumor and soft tissue sarcoma. 
   
   
       2 . The pharmaceutical composition according to Claim  1 , wherein the elm tree is in  Ulmus hollandica.    
   
   
       3 . The pharmaceutical composition according to Claim  2 , wherein the elm tree is selected from the group consisting of vegeta, commelin, groenveid, belgica, clusius, columella, dodoens and homestead. 
   
   
       4 . The pharmaceutical composition according to Claim  3 , wherein the elm tree is selected from the group consisting of vegeta, commelin and groenveid. 
   
   
       5 . The pharmaceutical composition according to  claim 1 , comprising dried powder of the flowery portion of elm tree and dried powder of the leaf portion of varnish tree. 
   
   
       6 . The pharmaceutical composition according to  claim 1 , comprising extract of the flowery portion of elm tree and extract of the leaf portion of varnish tree. 
   
   
       7 . (canceled) 
   
   
       8 . A method of treating a cancer selected from the group consisting of malignant sarcoma, malignant adenoma, hemangiosarcoma, non-Hodgkin lymphoma, mesenchymal tumor and soft tissue sarcoma comprising administering to a subject having such a cancer an effective amount of the composition in accordance with  claim 1 . 
   
   
       9 . The method according to  claim 8 , wherein the cancer is malignant sarcoma. 
   
   
       10 . The method according to  claim 8 , wherein the cancer is malignant adenoma. 
   
   
       11 . The method according to  claim 8 , wherein the cancer is hemangiosarcoma. 
   
   
       12 . The method according to  claim 8 , wherein the cancer is non-Hodgkin lymphoma. 
   
   
       13 . The method according to  claim 8 , wherein the cancer is mesenchymal tumor. 
   
   
       14 . The method according to  claim 8 , wherein the cancer is soft tissue sarcoma.